DIAGMMR® -
DIAGNOSTICS INNOVATION

OUR MISSION IS TO SAVE LIVES THROUGH THE EARLY DETECTION OF LYNCH SYNDROME
WITH AN EASY AND ACCURATE DIAGNOSTIC METHOD.

LYNCH SYNDROME

1 in 279 people have Lynch syndrome, i.e. inherited mismatch repair (MMR) deficiency, making it the most common cause of hereditary colon and uterine cancers.

INHERITED DEFECT

Lynch syndrome (LS) is inherited with 50% probability within affected families. Each single year, more than 2 million new cancer cases should be tested for LS.

INDIVIDUAL RISK

Individuals with inherited MMR deficiency have an up to 80% risk of developing cancer and at a significantly younger age than the general population.

INNOVATIVE SOLUTION

The DiagMMR® method developed by LS CancerDiag is a simple and accurate test to reliably detect Lynch syndrome, enabling preventive care and helping save lives.